Wake Forest University School of Medicine, Advocate Health and Vysnova Partners have been awarded a $3.4 million, four-year contract to study HIV, Mpox and other sexually transmitted infections (STIs).
Tag: mpox
Faster Monkeypox (mpox) Testing Through CRISPR
Mpox, formerly known as monkeypox, is a rare viral disease that is spread through physical contact between people.
Reductions in sexual mixing ended mpox outbreak in England, while vaccination has prevented resurgences in 2023
The rapid outbreak of mpox (formerly known as monkeypox) in 2022 likely resulted from high levels of sexual mixing among some gay, bisexual and other men who have sex with men (GBMSM), with the initial downturn in cases probably due to a reduction in sexual contacts among these men.
Researchers describe case of tecovirimat-resistant mpox variant in patient with prolonged infection
Authors from the Institute of Tropical Medicine, Nationalestraat, Antwerp, Belgium describe a case of tecovirimat-resistant mpox virus (MPXV) identified at the autopsy of a severely immunocompromised patient with prolonged disease. Tecovirimat, an antiviral used to treat severe mpox virus, has a low barrier to resistance, which makes this case particularly unusual. The case report is published in Annals of Internal Medicine.
A UCLA-led team has received a $925,000 CDC grant to track mpox outbreaks across the US
A UCLA-led team has received $925,000 as part of a new grant from the Centers for Disease Control and Prevention (CDC) to conduct four surveillance projects tracking outbreaks of mpox–formerly known as monkeypox—across the U.S.
Mpox Antiviral Outcomes Are Similar Regardless of HIV Status
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Mpox modeling suggests timely detection, isolation could prevent significant spread on college campuses
A model of mpox transmission among students living on a college campus suggests that sustained transmission could be significantly reduced with timely detection and isolation on its own. The model also showed that preventative vaccination of the high-risk population could help limit the size and scope of outbreaks. The findings are published in Annals of Internal Medicine.
What You Should Know About Mpox
Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.
Early engagement with affected communities helped to control mpox outbreak in Montreal
An analysis of the first large mpox outbreak in North America found that early, sustained engagement and rapid offering of preexposure vaccination to affected communities successfully controlled the spread of the outbreak. The analysis is published in Annals of Internal Medicine.